Assoz. Prof. Mag. Dr. Johannes Kirchmair
Johannes Kirchmair
101 - 120 out of 127
Chimenti F, Secci D, Bolasco A, Chimenti P, Granese A, Carradori S et al. Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors. Bioorganic & Medicinal Chemistry. 2010 Jul 15;18(14):5063-5070. doi: 10.1016/j.bmc.2010.05.070

Schuster D, Kern L, Hristozov DP, Terfloth L, Bienfait B, Laggner C et al. Applications of Integrated Data Mining Methods to Exploring Natural Product Space for Acetylcholinesterase Inhibitors. Combinatorial Chemistry & High Throughput Screening. 2010 Jan;13(1):54-66. doi: http://dx.doi.org/10.2174/138620710790218212




Markt P, Feldmann C, Rollinger JM, Raduner S, Schuster D, Kirchmair J et al. Discovery of Novel CB2 Receptor Ligands by a Pharmacophore-Based Virtual Screening Workflow. Journal of Medicinal Chemistry. 2009 Jan 22;52(2):369-378. doi: 10.1021/jm801044g

Tiikkainen P, Markt P, Wolber G, Kirchmair J, Distinto S, Poso A et al. Critical Comparison of Virtual Screening Methods against the MUV Data Set. Journal of Chemical Information and Modeling. 2009;49(10):2168–2178. doi: 10.1021/ci900249b

Kirchmair J, Distinto S, Markt P, Schuster D, Spitzer GM, Liedl KR et al. How To Optimize Shape-Based Virtual Screening: Choosing the Right Query and Including Chemical Information. Journal of Chemical Information and Modeling. 2009;49(3):678–692. doi: 10.1021/ci8004226


Kirchmair J, Markt P, Distinto S, Schuster D, Spitzer GM, Liedl KR et al. The Protein Data Bank (PDB), Its Related Services and Software Tools as Key Components for In Silico Guided Drug Discovery. Journal of Medicinal Chemistry. 2008 Nov 27;51(22):7021-7040. doi: 10.1021/jm8005977




Markt P, McGoohan C, Walker B, Kirchmair J, Feldmann CL, De Martino G et al. Discovery of novel cathepsin S inhibitors by pharmacophore-based virtual high-throughput screening. Journal of Chemical Information and Modeling. 2008 Aug;48(8):1693-1705. doi: 10.1021/ci800101j



Kirchmair J, Distinto S, Schuster D, Spitzer G, Langer T, Wolber G. Enhancing drug discovery through in silico screening: Strategies to increase true positives retrieval rates. Current Medicinal Chemistry. 2008;15(20):2040-2053. doi: 10.2174/092986708785132843

Laggner C, Wolber G, Kirchmair J, Schuster D, Langer T. Pharmacophore-based Virtual Screening in Drug Discovery. In Varnek A, Tropsha A, editors, Chemoinformatics Approaches to Virtual Screening. Cambridge: RSC Publishing. 2008. p. 76-119 doi: 10.1039/9781847558879-00076

Markt P, Schuster D, Kirchmair J, Laggner C, Langer T. Pharmacophore modeling and parallel screening for PPAR ligands. Journal of Computer-Aided Molecular Design. 2007 Oct;21(10-11):575-590. doi: 10.1007/s10822-007-9140-0


101 - 120 out of 127

Maximizing the performance of similarity-based virtual screening methods

Johannes Kirchmair (Speaker)

19 Apr 2023

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico methods for flagging compounds that are likely to interfere with biological assays

Johannes Kirchmair (Invited speaker)

16 Dec 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Cheminformatics in natural product-based drug discovery

Johannes Kirchmair (Invited speaker)

24 Nov 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


From in silico to in vivo - Psychotria nemorosa alkaloids counter protein toxicity in Caenorhabditis elegans

Benjamin Kirchweger (Speaker), Luiz C Klein-Junior (Contributor), Dagmar Pretsch (Contributor), Ya Chen (Contributor), Sylvian Cretton (Contributor), Andre Luis de Gasper (Contributor), Yvan Vander Heyden (Contributor), Philippe Christen (Contributor), Johannes Kirchmair (Contributor), Amélia T Henriques (Contributor) & Judith Maria Rollinger (Contributor)

31 Aug 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Natural products against SARS-CoV-2 or how to catch a butterfly?

Andreas Wasilewicz (Speaker), Benjamin Kirchweger (Contributor), Denisa Bojkova (Contributor), Marie Jose Abi Saad (Contributor), Julia Langeder (Contributor), Ulrike Grienke (Contributor), Jindrich Cinatl (Contributor), Julien Orts (Contributor), Johannes Kirchmair (Contributor), Holger F. Rabenau (Contributor) & Judith Maria Rollinger (Contributor)

31 Aug 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Cheminformatics in Natural Product-Based Drug Discovery

Johannes Kirchmair (Keynote speaker)

30 Aug 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computerbasierte Vorhersage des Metabolismus von Wirkstoffen

Johannes Kirchmair (Invited speaker)

12 Jul 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Cheminformatics in natural product-based drug discovery

Johannes Kirchmair (Invited speaker)

30 Jun 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Introduction to machine learning in early drug discovery

Johannes Kirchmair (Invited speaker)

21 Jun 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico and in vitro Approach to Assess Direct Allosteric AMPK Activators from Nature

Benjamin Kirchweger (Speaker), Andreas Wasilewicz (Contributor), Katrin Fischhuber (Contributor), Ammar Tahir (Contributor), Ya Chen (Contributor), Elke Heiß (Contributor), Thierry Langer (Contributor), Johannes Kirchmair (Contributor) & Judith Maria Rollinger (Contributor)

20 May 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico prediction of xenobiotic metabolism

Johannes Kirchmair (Invited speaker)

19 May 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico prediction of drug metabolism

Johannes Kirchmair (Invited speaker)

4 May 2022

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational prediction of the metabolic fate of small molecules

Johannes Kirchmair (Speaker)

28 Sep 2021

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational methods for flagging compounds likely to cause false outcomes in biological assays

Johannes Kirchmair (Speaker)

7 Jun 2021

Activity: Talks and presentationsTalk or oral contributionScience to Science


In silico prediction of the macromolecular targets of natural products

Johannes Kirchmair (Speaker)

9 Mar 2021

Activity: Talks and presentationsTalk or oral contributionScience to Science


Computational prediction of xenobiotic metabolism (focus on AI/machine learning methods)

Johannes Kirchmair (Speaker)

27 Jan 2021

Activity: Talks and presentationsTalk or oral contributionScience to Science


Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien

T: +43-1-4277-55104

johannes.kirchmair@univie.ac.at